Bacterial Cell Culture Market Report 2026

The bacterial cell culture market size has grown strongly in recent years. It will grow from $3.44 billion in 2025 to $3.73 billion in 2026 at a compound annual growth rate (CAGR) of 8.2%. The growth in the historic period can be attributed to expansion of microbiology research laboratories, routine use in clinical diagnostics, growth of food safety testing requirements, adoption in academic research settings, standardized bacterial growth protocols.

The bacterial cell culture market size is expected to see strong growth in the next few years. It will grow to $5.05 billion in 2030 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to increasing demand for rapid microbial diagnostics, expansion of biopharmaceutical fermentation processes, rising focus on antimicrobial resistance research, growth of environmental testing programs, integration with automated laboratory workflows. Major trends in the forecast period include increasing demand for high-purity culture media, rising adoption of automated microbial culturing systems, growing use in biopharmaceutical manufacturing, expansion of food and water safety testing, enhanced focus on rapid pathogen detection.

The increasing prevalence of infectious diseases is expected to drive the growth of the bacterial cell culture market in the coming years. Infectious diseases are caused by microorganisms such as bacteria, viruses, fungi, or parasites, and can be transmitted from one person or organism to another. The rise in infectious diseases is attributed to the growth of global travel, which enables pathogens to spread quickly across regions and populations that were previously isolated. Bacterial cell culture supports the study of infectious diseases by allowing researchers to grow and analyze bacteria in a controlled environment, facilitating accurate identification and the development of targeted treatments. For example, in October 2024, the Center for Infectious Disease Research and Policy, a US-based public organization, reported that the estimated total number of people who contracted TB, including undiagnosed cases, rose to 10.8 million in 2023, compared to 10.7 million in 2022. Consequently, the rising prevalence of infectious diseases is fueling the growth of the bacterial cell culture market.

Major companies operating in the bacterial cell culture market are concentrating on developing advanced technologies, such as automated culturing systems, to enable high-throughput experiments. Automated culturing technology refers to systems that utilize machines and software to efficiently grow and monitor cell or microbial cultures with minimal manual intervention. For example, in September 2023, OGI Bio, a Scotland-based biotechnology company, introduced the Mk2 Microbial Culturing System, the next generation of automated cell culturing technology. Building on the capabilities of previous models, the Mk2 provides higher performance, enhanced functionality, and user-friendly operation to address the requirements of modern research laboratories. It offers improved efficiency, reliability, and flexibility for automating microbial culture experiments. The system allows researchers to track microbial growth, dissolved oxygen, and fluorescent signals, while the Turbidostat pump enables precise regulation of these parameters for the first time. With these advancements, the Mk2 functions as a powerful tool for progressing research in microbiology, biotechnology, and synthetic biology.

In April 2025, Sartorius, a Germany-based life science company, formed a partnership with Mabion S.A. to advance biopharmaceutical development. Through this collaboration, Sartorius and Mabion will provide a comprehensive suite of integrated biopharmaceutical development services. Sartorius will concentrate on lab-scale development, utilizing its cell culture media and expertise in cell line and upstream process optimization, while Mabion will manage advanced upstream development, 10L bioreactor confirmation, downstream process optimization, analytics, validation, scale-up, and large-scale manufacturing. Mabion S.A. is a Poland-based contract development and manufacturing organization.

Major companies operating in the bacterial cell culture market are Danaher Corporation, Thermo Fisher Scientific Inc., Merck KGaA, Corning Incorporated, Lonza Group AG, Avantor Inc., Cytiva, Sartorius AG, FUJIFILM Irvine Scientific, Bio-Techne Corporation, Repligen Corporation, Takara Bio Inc., Becton Dickinson and Company, HiMedia Laboratories Pvt. Ltd., Capricorn Scientific GmbH, Athena Environmental Services Inc., Genexis Biotech Pvt. Ltd., BioProcess Technologies Ltd., Athena Medical Products Inc., Jin Kairui Biotechnology Co. Ltd.

North America was the largest region in the bacterial cell culture market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bacterial cell culture market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the bacterial cell culture market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the bacterial cell culture market by increasing costs of imported culture media components, reagents, sterile consumables, incubators, and analytical instruments. Diagnostic centers and research laboratories in North America and Europe are most affected due to reliance on imported microbiology supplies, while Asia-Pacific faces higher costs for export-oriented consumables. These tariffs elevate laboratory operating expenses and procurement lead times. However, they also promote domestic production of media and reagents, regional manufacturing of consumables, and localized supply chain development.

The bacterial cell culture market research report is one of a series of new reports that provides bacterial cell culture market statistics, including bacterial cell culture industry global market size, regional shares, competitors with a bacterial cell culture market share, detailed bacterial cell culture market segments, market trends and opportunities, and any further data you may need to thrive in the bacterial cell culture industry. This bacterial cell culture market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Bacterial cell culture involves the regulated growth of bacterial cells in a laboratory setting. It requires establishing conditions such as appropriate nutrients, temperature, and pH that promote bacterial growth and survival. This method allows for in-depth examination of bacterial behavior, physiology, and biological properties under consistent and reproducible conditions.

The main product types of bacterial cell culture include media, reagents, sera, consumables, and others. Bacterial cell culture media is a nutrient-rich material specifically designed to support the growth, maintenance, and proliferation of bacterial cells under controlled laboratory conditions. It is used for various cell types such as gram-positive bacteria, gram-negative bacteria, anaerobic bacteria, thermophilic bacteria, and others and is applied for disease diagnosis, food testing, water testing, biopharmaceutical production, research laboratories, and others. It is utilized by several end users, including diagnostic centers, the food industry, and others.

The bacterial cell culture market consists of sales of agar plates, inoculating loops, petri dishes, centrifuges, and cryopreservation systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.